Adiponectin Receptor 1-vascular endothelial growth factor axis mediates resistance to epidermal growth factor receptor-targeted therapy in nasopharyngeal carcinoma.

Saved in:
Bibliographic Details
Title: Adiponectin Receptor 1-vascular endothelial growth factor axis mediates resistance to epidermal growth factor receptor-targeted therapy in nasopharyngeal carcinoma.
Authors: Cheng Z; Department of Otolaryngology, Head and Neck Surgery., Peng X; Department of Otolaryngology, Head and Neck Surgery., Wu S; Department of Otolaryngology, Head and Neck Surgery., Li W; Department of Outpatient, Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou., Liu X; Department of Otolaryngology, Head and Neck Surgery., Zhang G; Department of Otolaryngology, Xiaolan Clinical Institute of Shantou University Medical College, Zhongshan, Guangdong Province, China.
Source: Anti-cancer drugs [Anticancer Drugs] 2026 Feb 01; Vol. 37 (2), pp. 146-156. Date of Electronic Publication: 2025 Nov 03.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-5741
DOI:10.1097/CAD.0000000000001766